Non-Small Cell Lung Cancer

When you come to us for diagnosis or treatment for non-small cell lung cancer, you can typically see each member of our group on the same day. Your team may include pulmonologists, thoracic surgeons, medical oncologists, radiation oncologists, and interventional radiologists. This multidisciplinary team of internationally renowned experts creates a treatment plan that’s customized for you.

We use a variety of tests on tissue and blood to learn as much about the lung cancer as possible, helping us create the best treatment plan for you.

Our clinical trials can provide the newest therapeutic options, such as targeted drugs and immunotherapy. We also offer many supportive services, such as lung rehabilitation, psychological care, and integrative health therapies.

Clinical Trials and Research Studies

Phase 2

A Phase 2 Open-label Multicenter Randomized Multidrug Platform Study of Neoadjuvant Durvalumab Alone or in Combination with Novel Agents in Subjects with Resectable Early-stage (I [> 2 cm] to IIIA) Non-small Cell Lung Cancer (NeoCOAST)

Learn More

Phase 1/2

A Phase 1/2 Study of Oral LOXO-292 in Patients With Advanced Solid Tumors Including RET Fusion-Positive Solid Tumors Medullary Thyroid Cancer and Other Tumors With RET Activation (LIBRETTO-001)

Learn More

Phase N/A

Feasibility study to treat lung cancer with the permanently implantable LDR CivaSheet

Learn More

Phase 1

A Phase 1 First-in-Human Open-Label Dose Escalation Study of JNJ-61186372 a Human Bispecific EGFR and cMet Antibody in Subjects with Advanced Non-Small Cell Lung Cancer

Learn More